Search for:
About Us
The Wheeler Difference
The Wheeler Team
Board of Advisors
Board of Directors
CRO Partnerships
Portable CMC
®
The Benefits of Portable CMC
®
Portable CMC
®
Services
Lead to Manufacturability
Lead to Tox
Lead to Clinic
Services
Custom Development Services
Transient Protein Expression
Cell Line Development
Process Development & Optimization
Analytical Development & Qualification
Process Characterization
Technology Transfer
Toxicology Material Supply
Formulation Development
GMP Services
CGMP Master Cell Banking
CGMP Drug Substance Manufacturing
CDMO Vision
Facilities
Oklahoma City Innovation Ecosystem
Careers
News + Media
Contact Us
Enter a term to search
Search for:
Wheeler Bio Announces Closing of $31 Million Series A Round Supporting its Clinical (CGMP) Drug Substance Manufacturing Facility in Oklahoma City
All
Articles
Blogs
Events
News + PR
Resources
Videos